A citation-based method for searching scientific literature

Elwin J C Rombouts, Biljana Pavic, Bob Löwenberg, Rob E Ploemacher. Blood 2004
Times Cited: 224







List of co-cited articles
944 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.
Zhihong Zeng, Yue Xi Shi, Ismael J Samudio, Rui-Yu Wang, Xiaoyang Ling, Olga Frolova, Mark Levis, Joshua B Rubin, Robert R Negrin, Elihu H Estey,[...]. Blood 2009
379
47

A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia.
Geoffrey L Uy, Michael P Rettig, Ibraheem H Motabi, Kyle McFarland, Kathryn M Trinkaus, Lindsay M Hladnik, Shashikant Kulkarni, Camille N Abboud, Amanda F Cashen, Keith E Stockerl-Goldstein,[...]. Blood 2012
291
45

CXCR4 is a prognostic marker in acute myelogenous leukemia.
Anke C Spoo, Michael Lübbert, William G Wierda, Jan A Burger. Blood 2007
238
43

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.
Bruno Nervi, Pablo Ramirez, Michael P Rettig, Geoffrey L Uy, Matthew S Holt, Julie K Ritchey, Julie L Prior, David Piwnica-Worms, Gary Bridger, Timothy J Ley,[...]. Blood 2009
374
41

Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype.
Sergej Konoplev, Georgios Z Rassidakis, Elihu Estey, Hagop Kantarjian, Chrysoula I Liakou, Xuelin Huang, Lianchun Xiao, Michael Andreeff, Marina Konopleva, L Jeffrey Medeiros. Cancer 2007
118
37

CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice.
Sigal Tavor, Isabelle Petit, Svetlana Porozov, Abraham Avigdor, Ayelet Dar, Leonor Leider-Trejo, Noga Shemtov, Varda Deutsch, Ella Naparstek, Arnon Nagler,[...]. Cancer Res 2004
265
30


Dynamic chemotherapy-induced upregulation of CXCR4 expression: a mechanism of therapeutic resistance in pediatric AML.
Edward Allan R Sison, Emily McIntyre, Daniel Magoon, Patrick Brown. Mol Cancer Res 2013
78
32

Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia.
Takuya Matsunaga, Naofumi Takemoto, Tsutomu Sato, Rishu Takimoto, Ikuta Tanaka, Akihito Fujimi, Takehide Akiyama, Hiroyuki Kuroda, Yutaka Kawano, Masayoshi Kobune,[...]. Nat Med 2003
412
23

Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy.
Byung-Sik Cho, Zhihong Zeng, Hong Mu, Zhiqiang Wang, Sergej Konoplev, Teresa McQueen, Marina Protopopova, Jorge Cortes, Joseph R Marszalek, Sheng-Bin Peng,[...]. Blood 2015
79
29

BMS-936564/MDX-1338: a fully human anti-CXCR4 antibody induces apoptosis in vitro and shows antitumor activity in vivo in hematologic malignancies.
Michelle R Kuhne, Tanya Mulvey, Blake Belanger, Sharline Chen, Chin Pan, Colin Chong, Fei Cao, Wafa Niekro, Tom Kempe, Karla A Henning,[...]. Clin Cancer Res 2013
155
22

Leukemia stem cells and microenvironment: biology and therapeutic targeting.
Marina Y Konopleva, Craig T Jordan. J Clin Oncol 2011
296
20

Targeting of CD44 eradicates human acute myeloid leukemic stem cells.
Liqing Jin, Kristin J Hope, Qiongli Zhai, Florence Smadja-Joffe, John E Dick. Nat Med 2006
854
20

The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation.
S Tavor, M Eisenbach, J Jacob-Hirsch, T Golan, I Petit, K Benzion, S Kay, S Baron, N Amariglio, V Deutsch,[...]. Leukemia 2008
78
23

Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells.
Angela Colmone, Maria Amorim, Andrea L Pontier, Sheng Wang, Elizabeth Jablonski, Dorothy A Sipkins. Science 2008
434
18

CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia.
Ye Chen, Rodrigo Jacamo, Marina Konopleva, Ramiro Garzon, Carlo Croce, Michael Andreeff. J Clin Invest 2013
145
16

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.
T Lapidot, C Sirard, J Vormoor, B Murdoch, T Hoang, J Caceres-Cortes, M Minden, B Paterson, M A Caligiuri, J E Dick. Nature 1994
16

CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model.
Y Zhang, S Patel, H Abdelouahab, M Wittner, C Willekens, S Shen, A Betems, V Joulin, P Opolon, O Bawa,[...]. Cell Death Dis 2012
47
34

Role of CXCR4 in the pathogenesis of acute myeloid leukemia.
Amnon Peled, Sigal Tavor. Theranostics 2013
70
21

CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure.
Michael Fiegl, Ismael Samudio, Karen Clise-Dwyer, Jared K Burks, Zakar Mnjoyan, Michael Andreeff. Blood 2009
96
14

Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.
Fumihiko Ishikawa, Shuro Yoshida, Yoriko Saito, Atsushi Hijikata, Hiroshi Kitamura, Satoshi Tanaka, Ryu Nakamura, Toru Tanaka, Hiroko Tomiyama, Noriyuki Saito,[...]. Nat Biotechnol 2007
673
14

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
Hartmut Döhner, Elihu Estey, David Grimwade, Sergio Amadori, Frederick R Appelbaum, Thomas Büchner, Hervé Dombret, Benjamin L Ebert, Pierre Fenaux, Richard A Larson,[...]. Blood 2017
14

Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia.
Emmanuelle Tavernier-Tardy, Jérôme Cornillon, Lydia Campos, Pascale Flandrin, Amélie Duval, Nathalie Nadal, Denis Guyotat. Leuk Res 2009
51
25


Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias.
Zhihong Zeng, Ismael J Samudio, Mark Munsell, Jing An, Ziwei Huang, Elihu Estey, Michael Andreeff, Marina Konopleva. Mol Cancer Ther 2006
143
13

Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance.
Rodrigo Jacamo, Ye Chen, Zhiqiang Wang, Wencai Ma, Min Zhang, Erika L Spaeth, Ying Wang, Venkata L Battula, Po Yee Mak, Katharina Schallmoser,[...]. Blood 2014
186
13

The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression.
M Abraham, S Klein, B Bulvik, H Wald, I D Weiss, D Olam, L Weiss, K Beider, O Eizenberg, O Wald,[...]. Leukemia 2017
66
19

High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia.
R Crazzolara, A Kreczy, G Mann, A Heitger, G Eibl, F M Fink, R Möhle, B Meister. Br J Haematol 2001
158
12

Osteoblastic cells regulate the haematopoietic stem cell niche.
L M Calvi, G B Adams, K W Weibrecht, J M Weber, D P Olson, M C Knight, R P Martin, E Schipani, P Divieti, F R Bringhurst,[...]. Nature 2003
12


The prognostic value of CXCR4 in acute myeloid leukemia.
Jeong Yeal Ahn, Katie Seo, Olga K Weinberg, Daniel A Arber. Appl Immunohistochem Mol Morphol 2013
32
37


Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.
Byung-Sik Cho, Hee-Je Kim, Marina Konopleva. Korean J Intern Med 2017
56
21


Migratory behavior of leukemic cells from acute myeloid leukemia patients.
C Voermans, W P M van Heese, I de Jong, W R Gerritsen, C E van Der Schoot. Leukemia 2002
76
14

Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia.
Marc H G P Raaijmakers, Siddhartha Mukherjee, Shangqin Guo, Siyi Zhang, Tatsuya Kobayashi, Jesse A Schoonmaker, Benjamin L Ebert, Fatima Al-Shahrour, Robert P Hasserjian, Edward O Scadden,[...]. Nature 2010
746
11

CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance.
Adam Greenbaum, Yen-Michael S Hsu, Ryan B Day, Laura G Schuettpelz, Matthew J Christopher, Joshua N Borgerding, Takashi Nagasawa, Daniel C Link. Nature 2013
830
11

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche.
Simón Méndez-Ferrer, Tatyana V Michurina, Francesca Ferraro, Amin R Mazloom, Ben D Macarthur, Sergio A Lira, David T Scadden, Avi Ma'ayan, Grigori N Enikolopov, Paul S Frenette. Nature 2010
11

CXCL12 (SDF-1)/CXCR4 pathway in cancer.
Beverly A Teicher, Simon P Fricker. Clin Cancer Res 2010
932
11


Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche.
Maher Hanoun, Dachuan Zhang, Toshihide Mizoguchi, Sandra Pinho, Halley Pierce, Yuya Kunisaki, Julie Lacombe, Scott A Armstrong, Ulrich Dührsen, Paul S Frenette. Cell Stem Cell 2014
237
11

G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.
Isabelle Petit, Martine Szyper-Kravitz, Arnon Nagler, Meir Lahav, Amnon Peled, Liliana Habler, Tanya Ponomaryov, Russell S Taichman, Fernando Arenzana-Seisdedos, Nobutaka Fujii,[...]. Nat Immunol 2002
11

Acute myeloid leukaemia.
Elihu Estey, Hartmut Döhner. Lancet 2006
923
11

In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment.
Dorothy A Sipkins, Xunbin Wei, Juwell W Wu, Judith M Runnels, Daniel Côté, Terry K Means, Andrew D Luster, David T Scadden, Charles P Lin. Nature 2005
584
11

BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.
Eleni D Lagadinou, Alexander Sach, Kevin Callahan, Randall M Rossi, Sarah J Neering, Mohammad Minhajuddin, John M Ashton, Shanshan Pei, Valerie Grose, Kristen M O'Dwyer,[...]. Cell Stem Cell 2013
739
11




Arteriolar niches maintain haematopoietic stem cell quiescence.
Yuya Kunisaki, Ingmar Bruns, Christoph Scheiermann, Jalal Ahmed, Sandra Pinho, Dachuan Zhang, Toshihide Mizoguchi, Qiaozhi Wei, Daniel Lucas, Keisuke Ito,[...]. Nature 2013
759
10

Identification of the haematopoietic stem cell niche and control of the niche size.
Jiwang Zhang, Chao Niu, Ling Ye, Haiyang Huang, Xi He, Wei-Gang Tong, Jason Ross, Jeff Haug, Teri Johnson, Jian Q Feng,[...]. Nature 2003
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.